UPA Retlira 30mg Pen - Retatrutide

RETLIRA is a powerful triple-action peptide therapy containing 30mg of Retatrutide, a new-generation weight loss compound targeting:
GLP-1 receptors – reduces appetite and stabilizes blood sugar
GIP receptors – improves insulin sensitivity
Glucagon receptors – boosts fat burning and metabolism
RETLIRA mimics three key metabolic hormones in one weekly injection,
outperforming older GLP-1 options like Semaglutide and Tirzepatide.

High-strength Retatrutide – clinically backed for fat loss & amp; glucose control
Convenient pre-filled 30mg pen
Ideal for those who’ve plateaued on Semaglutide or Tirzepatide
Supports long-term appetite regulation, visceral fat loss, and insulin
improvement
Used in cutting-edge obesity protocols
Triple action. One injection. Total transformation.

Dosing Adjustable dial, 2.5mg–10mg per week
Injection Type Subcutaneous (abdomen, thigh, upper arm)
Use Once per week
Storage Refrigerate unopened (2–8°C). Store up to 30 days, once opened at below 25°C.

Format Prefilled, dial-dose pen (multi-week use)
One pen lasts 2 to 12 weeks, depending on dosage. Use once weekly on the same day each week.

DOSAGE CALCULATOR  
Suggested Volume to Dial (ml @ Effective Dose 10mg/ml)
Week 1–2  2.5mg Intro phase – reduce nausea

Week 3      5.0mg - Appetite control begins
Week 4      7.5mg - Fat burn stage
Week 5 onwards   10mg -  Full therapeutic level

Box contains:        1 Pen and 8 Disposable Needles.